DUAKLIR

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug DUAKLIR contains a combination of these active pharmaceutical ingredients (APIs):

1	Aclidinium UNII UQW7UF9N91 - ACLIDINIUM BROMIDE
	Aclidinium is a competitive, selective muscarinic receptor antagonist (also known as an anticholinergic), with a longer residence time at the M3 receptors than the M2 receptors. M3 receptors mediate contraction of airway smooth muscle. Inhaled aclidinium acts locally in the lungs to antagonise M3 receptors of airway smooth muscle and induce bronchodilation.
	Read more about Aclidinium
2	Eformoterol UNII W34SHF8J2K - FORMOTEROL FUMARATE
	Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.
	Read more about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DUAKLIR GENUAIR Inhalation powder	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AL05	Formoterol and aclidinium bromide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02439530
EE	Ravimiamet	1669710, 1669721, 1727849
ES	Centro de información online de medicamentos de la AEMPS	114964001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	077994, 454210
GB	Medicines & Healthcare Products Regulatory Agency	283575
HK	Department of Health Drug Office	64503
IL	מִשְׂרַד הַבְּרִיאוּת	7812
LT	Valstybinė vaistų kontrolės tarnyba	1075095, 1075096, 1080832
NL	Z-Index G-Standaard, PRK	122734
PL	Rejestru Produktów Leczniczych	100332957
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69355001
SG	Health Sciences Authority	15231P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699786550131, 8699786550148, 8699786550155
US	FDA, National Drug Code	72124-001